[1]
M. Pisaturo, A. Russo, L. Onorato, and N. Coppola, “Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis”, ABM, vol. 90, no. 2, pp. 187-196, May 2019.